EQL Pharma AB (EQL)

Stockholm

Currency in SEK

23.4000

+0.4000(+1.74%)

Real-time Data·25/09

Fair Value

Unlock Value

Day's Range

23.0000

24.0000

52 wk Range

17.3800

70.6000

EQL Income Statement

Assess the EQL Pharma income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the EQL net worth.

Period Ending:

2017

31/12

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

2025

31/03

2026

31/03

Total Revenues

aa.aa

409.75

259.91

264.17

373.52

432.66

Total Revenues Growth

aa.aa

+128.73%

-36.57%

+1.64%

+41.39%

+15.83%

Cost Of Revenues

aa.aa

314.02

144.06

149.12

217.56

269.82

Gross Profit

aa.aa

95.73

115.85

115.05

155.95

162.84

Gross Profit Growth

aa.aa

+87.69%

+21.01%

-0.69%

+35.56%

+4.42%

Gross Profit Margin %

aa.aa

23.36%

44.57%

43.55%

41.75%

37.64%

Other Operating Expenses, Total

aa.aa

56.9

74.51

82.43

89.2

115.06

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+44.1%	+30.96%	+10.63%	+8.22%	+28.99%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	9.13	15.14	12.09	11.26	14.33
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	48.16	59.79	70.8	78.46	102.92
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-0.4	-0.41	-0.46	-0.52	-2.19

Operating Income

aa.aa

38.84

41.34

32.62

66.75

47.78

Operating Income Growth

aa.aa

+237.09%

+6.44%

-21.1%

+104.66%

-28.42%

EBIT Margin %

aa.aa

9.48%

15.9%

12.35%

17.87%

11.04%

Net Interest Expenses

aa.aa

-2.87

-2.37

-5.54

-12.33

-26.38

Net Interest Expenses Growth

aa.aa

-161.27%

+17.5%

-133.53%

-122.72%

-113.95%

Interest Expense, Total

aa.aa

-2.87

-2.37

-5.73

-12.34

-26.39

Interest And Investment Income

aa.aa

0.2

0.01

Other Non Operating Expenses, Total

aa.aa

-0

-0.68

-4.1

EBT, Excl. Unusual Items

aa.aa

35.97

38.97

27.08

53.74

17.3

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

0.62

0.91

EBT, Incl. Unusual Items

aa.aa

35.97

38.97

28.6

54.36

18.21

EBT, Incl. Unusual Items Growth

aa.aa

+245.1%

+8.35%

-26.6%

+90.03%

-66.51%

EBT, Incl. Unusual Items Margin

aa.aa

8.78%

14.99%

10.83%

14.55%

4.21%

Income Tax Expense

aa.aa

4.42

8.05

5.9

11.23

5.67

Net Income to Company

aa.aa

31.55

30.92

22.71

43.12

12.54

Minority Interest

aa.aa

Net Income

aa.aa

31.55

30.92

22.71

43.12

12.54

Net Income Growth

aa.aa

+204.32%

-1.99%

-26.57%

+89.93%

-70.93%

Net Income Margin %

aa.aa

7.7%

11.9%

8.59%

11.55%

2.9%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

31.55

30.92

22.71

43.12

12.54

Basic EPS - Continuing Operations

aa.aa

1.09

1.06

0.78

1.48

0.42

Basic EPS - Continuing Operations Growth

aa.aa

+204.32%

-1.99%

-26.57%

+89.93%

-71.38%

Diluted EPS - Continuing Operations

aa.aa

1.09

1.04

0.76

1.44

0.42

Diluted EPS - Continuing Operations Growth

aa.aa

+204.32%

-4.19%

-26.92%

+89.47%

-70.83%

Basic Weighted Average Shares Outstanding

aa.aa

29.06

29.53

Diluted Weighted Average Shares Outstanding

aa.aa

29.06

29.53

29.8

29.9

30.17

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

40.54

47.37

38.81

75.06

65.93

EBITDA Growth

aa.aa

+144.69%

+16.86%

-18.08%

+93.43%

-12.16%

EBITDA Margin %

aa.aa

9.89%

18.23%

14.69%

20.1%

15.24%

EBIT

aa.aa

38.84

41.34

32.62

66.75

47.78

* In Millions of SEK (except for per share items)

S&P/TSX

35,800.89

+94.43

+0.26%

S&P/TSX 60

2,102.44

+5.54

+0.26%

US 30

51,546.70

-281.9

-0.54%

US 500

7,705.30

-38.2

-0.49%

S&P 500 VIX

16.30

+1.43

+9.62%

DAX

25,384.66

-11.56

-0.05%

Dollar Index

100.893

+0.185

+0.18%

Market Movers

Name	Last	Chg. %	Vol.
Canadian Natural	67.17	-0.96%	12.92M
RBC	285.63	+1.25%	2.39M
National Bank of Canada	212.23	+1.35%	2.81M
TC Energy	83.17	-1.29%	6.74M
Toronto Dominion Bank	170.69	+1.20%	2.81M
Enbridge	66.13	-1.28%	6.58M
Suncor Energy	96.57	-0.45%	3.32M

Name	Last	Chg. %	Vol.
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
ePlay Digital	0.010	+100.00%	7.00K
Greenhawk Resources	0.02	+100.00%	132.40K
Ramm Pharma	0.01	+100.00%	50.00K
Nuinsco Resources	0.0100	+100.00%	33.00K
Greenhawk Resources	0.0200	+100.00%	132.40K
Psyched Wellness	0.01	+100.00%	2.00K

Name	Last	Chg. %	Vol.
Playground Ventures	0.005	-66.67%	1.00K
Lanebury Growth Capital	0.06	-63.33%	4.00K
Molecule Holdings	0.005	-50.00%	20.11K
Hanstone Gold	0.02	-50.00%	13.00K
Enerev5 Metals	0.0050	-50.00%	5.00K
Affinity Metals	0.025	-50.00%	2.00K
Playgon Games	0.0050	-50.00%	1.12K

Trending Stocks

Name	Last	Chg. %	Vol.
Air Canada	27.34	-5.59%	4.81M
Equinox Gold	16.87	+1.81%	2.27M
Toronto Dominion Bank	170.69	+1.20%	2.81M
BCE Inc	29.69	-1.53%	5.48M
HIVE Digital Tech	4.4600	-4.29%	2.00M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
A Aaa Aa	16.74	+57.16%	26.31
Aaaaaaaaaaaaa	95.84	+55.57%	149.10
Aaa Aaaa	2.2700	+53.82%	3.4917
Aaaaaaaaa	8.06	+53.44%	12.37
Aaa Aaaaaa	113.31	+50.70%	170.76
Aaaaa Aa Aaaa	31.83	+48.08%	47.13
Aaa Aaaaa Aaaa A	15.85	+42.77%	22.63

Name	Last	Upside	Fair Value
A Aaa Aa	16.74	+57.16%	26.31
Aaaaaaaaaaaaa	95.84	+55.57%	149.10
Aaa Aaaa	2.2700	+53.82%	3.4917
Aaaaaaaaa	8.06	+53.44%	12.37
Aaa Aaaaaa	113.31	+50.70%	170.76
Aaaaa Aa Aaaa	31.83	+48.08%	47.13
Aaa Aaaaa Aaaa A	15.85	+42.77%	22.63

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

EQL Pharma AB (EQL)

EQL Income Statement

Trending Stocks